CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]
REVENUES	$ 426,454	$ 258,215	$ 154,080
Cost of product revenue	206,901	169,273	118,815
Gross profit	219,553	88,942	35,265
OPERATING EXPENSES:
Research and development	1,813	3,300	3,614
Plasma center operating expenses	4,245	4,266	17,843
Amortization of intangible assets	388	724	715
Selling, general and administrative	74,124	59,020	52,458
Total operating expenses	80,570	67,310	74,630
INCOME (LOSS) FROM OPERATIONS	138,983	21,632	(39,365)
OTHER INCOME (EXPENSE):
Interest income	2,097	1,617	45
Interest expense	(13,930)	(25,027)	(19,279)
Loss on extinguishment of debt	(1,243)	(26,174)	(6,670)
Other expense	(193)	(287)	(635)
Other expense, net	(13,269)	(49,871)	(26,539)
INCOME (LOSS) BEFORE INCOME TAXES	125,714	(28,239)	(65,904)
Income tax benefit	(71,959)	0	0
NET INCOME (LOSS)	$ 197,673	$ (28,239)	$ (65,904)
BASIC EARNINGS (LOSS) PER COMMON SHARE (in dollars per share)	$ 0.85	$ (0.13)	$ (0.33)
DILUTED EARNINGS (LOSS) PER COMMON SHARE (in dollars per share)	$ 0.81	$ (0.13)	$ (0.33)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:
Basic (in shares)	233,084,236	223,977,315	197,874,895
Diluted (in shares)	243,342,466	223,977,315	197,874,895